AIM: To investigate alternative splicing in vascular endothelial growth factor A (VEGFA), amyloid beta precursor protein (APP), and Numb homolog (NUMB) in colorectal cancer (CRC). METHODS: Real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and PCR-restriction fragment length polymorphism analyses were performed to detect the expression of VEGFA, APP, and NUMB mRNA in 20 CRC tissues and matched adjacent normal tissues, as well as their alternative splicing variants. RESULTS: qRT-PCR analysis revealed that the expression of APP, NUMB, and VEGFA165b mRNA were significantly downregulated, while VEGFA mRNA was upregulated, in CRC tissues (all P < 0.05). PCR-restriction fragment length polymorphism analysis revealed that the expression of VEGFA165a/b in CRC tissues was significantly higher than in adjacent normal tissues (P < 0.05). Compared with adjacent normal tissues, the expression of NUMB-PRR(S) in CRC tissues was significantly decreased (P < 0.05), and the expression of NUMB-PRR(L) was increased (P < 0.05). CONCLUSION: Alternative splicing of VEGFA, APP, and NUMB may regulate the development of CRC, and represent new targets for its diagnosis, prognosis, and treatment.
AIM: To investigate alternative splicing in vascular endothelial growth factor A (VEGFA), amyloid beta precursor protein (APP), and Numb homolog (NUMB) in colorectal cancer (CRC). METHODS: Real-time quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and PCR-restriction fragment length polymorphism analyses were performed to detect the expression of VEGFA, APP, and NUMB mRNA in 20 CRC tissues and matched adjacent normal tissues, as well as their alternative splicing variants. RESULTS: qRT-PCR analysis revealed that the expression of APP, NUMB, and VEGFA165b mRNA were significantly downregulated, while VEGFA mRNA was upregulated, in CRC tissues (all P < 0.05). PCR-restriction fragment length polymorphism analysis revealed that the expression of VEGFA165a/b in CRC tissues was significantly higher than in adjacent normal tissues (P < 0.05). Compared with adjacent normal tissues, the expression of NUMB-PRR(S) in CRC tissues was significantly decreased (P < 0.05), and the expression of NUMB-PRR(L) was increased (P < 0.05). CONCLUSION: Alternative splicing of VEGFA, APP, and NUMB may regulate the development of CRC, and represent new targets for its diagnosis, prognosis, and treatment.
Entities:
Keywords:
Alternative splicing; Amyloid beta precursor protein; Colorectal cancer; Numb homolog; Vascular endothelial growth factor A
Authors: Mahmud Bani-Yaghoub; Chris J Kubu; Rebecca Cowling; Jennifer Rochira; George N Nikopoulos; Stephen Bellum; Joseph M Verdi Journal: Dev Dyn Date: 2007-03 Impact factor: 3.780
Authors: Raul Catena; Vanessa Muniz-Medina; Beatriz Moralejo; Biola Javierre; Carolyn J M Best; Michael R Emmert-Buck; Jeffrey E Green; Carl C Baker; Alfonso Calvo Journal: Int J Cancer Date: 2007-05-15 Impact factor: 7.396
Authors: Ivan N Colaluca; Daniela Tosoni; Paolo Nuciforo; Francesca Senic-Matuglia; Viviana Galimberti; Giuseppe Viale; Salvatore Pece; Pier Paolo Di Fiore Journal: Nature Date: 2008-01-03 Impact factor: 49.962
Authors: Es Rennel; E Waine; H Guan; Y Schüler; W Leenders; J Woolard; M Sugiono; D Gillatt; Es Kleinerman; Do Bates; Sj Harper Journal: Br J Cancer Date: 2008-03-18 Impact factor: 7.640
Authors: R O Pritchard-Jones; D B A Dunn; Y Qiu; A H R Varey; A Orlando; H Rigby; S J Harper; D O Bates Journal: Br J Cancer Date: 2007-06-26 Impact factor: 7.640
Authors: M Kazemi; A Carrer; S Moimas; L Zandonà; R Bussani; B Casagranda; S Palmisano; P Prelazzi; M Giacca; L Zentilin; N De Manzini; M Giacca; S Zacchigna Journal: Cancer Gene Ther Date: 2016-04-01 Impact factor: 5.987